Journal
JOURNAL OF IMMUNOLOGICAL METHODS
Volume 508, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jim.2022.113325
Keywords
Acinetobacter baumannii; FilF; Immunoinformatics; Pilus assembly protein; Vaccine
Categories
Funding
- Indian Council of Medical Research (ICMR) , Government of India
- [BMI/11 (59) /2022]
Ask authors/readers for more resources
This study aimed to characterize the pilus assembly protein of A. baumannii and identify potential epitopes for vaccine development. Multiple antigenic B and T cell epitopes were recognized using bioinformatics tools, and selected based on their binding efficiency. A vaccine chimera was created by linking these epitopes with appropriate linkers and adjuvant. Homology modeling, molecular docking, and immune simulation were carried out to validate the efficacy of the vaccine construct.
Acinetobacter baumannii, a prominent pathogen responsible for chronic infections in the blood, urinary tract, and lungs, has a high mortality due to its virulence and limited preventive methods. The present study aims to characterize the pilus assembly protein of A. baumannii to offer leads for epitope-based vaccine development. FilF is the putative pilus assembly protein that reportedly plays a supreme character in the virulence of this WHO -listed ESKAPE bacterium. Implementing various bioinformatics tools, led to the recognition of many antigenic B and T cell epitopes. Most promising B and T-cell epitopes were selected based on their binding efficiency with commonly occurring MHC alleles. Finally, we stepped down to fourteen protective antigenic peptides. These epitopes were also revealed to be non-allergenic and non-toxic. As a result, a vaccine chimera was created by linking these epitopes with appropriate linkers and adjuvant such as beta-defensins. Furthermore, homology modeling and validation were carried out, with the modeled structure being employed for molecular docking with the immunological receptor (TLR-4) found on lymphocyte cells. As a result of the molecular dynamics simulation, the interaction between human TLR-4 and the multi-epitope vaccine sequence was stable. Finally, in silico cloning and immune simulation were carried out to see the efficacy of the construct vaccine. This is the first study targeting the pilus assembly protein from A. baumannii to identify novel epitopes that hold potential for further experimental design of multi-peptide vaccine construct against the pathogen.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available